“Divided by Regulations: How Conflicting AI Laws Threaten Global Collaboration in Life Sciences”
In a world where artificial intelligence is transforming the landscape of life sciences, a recent survey brings to light a critical issue—cross-border collaboration amidst varying AI regulations. Picture this: 85% of life science professionals admit they’re worried about how these differences can stall the momentum of collaborative research. With 83% already leveraging generative AI in their R&D endeavors, you’d think copyright concerns would be top of mind. Yet, 42% confess they hardly consider copyright when using AI tools. What gives? This dilemma was a central topic during The Pistoia Alliance’s annual conference in Philadelphia, where over 200 experts gathered to tackle pressing issues like AI regulation and data harmonization. As the pace of innovation races ahead, experts urge the industry to harmonize practices to ensure patient-centric outcomes. So, how do we bridge this gap and foster a culture of informed collaboration? The stakes are high, and the need for dialogue has never been more apparent. To dive deeper into these findings, click here to LEARN MORE.
Survey: 85 percent of lifescience professionals concerned about impact of differing AI regulations on cross-border collaboration
Post Comment